IV nutrition Pty Ltd is a proudly Australian-owned specialist in health food supply.
IV nutrition Pty Ltd has established itself as a leader in manufacturing and researching functional ingredients catering to the global health industry.
IV nutrition Pty Ltd nutritional research claims are not made lightly; they are grounded in a robust foundation of scientific validation.
These claims are substantiated through a variety of means, including human clinical studies, animal model studies, and in-vitro studies. In addition, the claims are fortified by the results of weight loss lifestyle trials and supported by anecdotal evidence.
IV nutrition Pty Ltd remains committed to its ongoing research efforts, which are meticulously designed to demonstrate the health benefits in alignment with food health claims regulations and complementary medicine regulations.
IV nutrition Pty Ltd focuses on a spectrum of health functions associated with its whole plant dietary fibre and prebiotics. These functions encompass:
IV nutrition Pty Ltd contributions to scientific research are noteworthy, as evidenced by the successful completion of PhD theses by three students-turned-doctors with a profound understanding of sugarcane prebiotic fibre impact on human health:
Numerous studies have established the vital connections between dietary fibre, prebiotics, microbiome alterations, and SCFA synthesis, all of which significantly influence digestive health outcomes. The following research snippets provide a glimpse into the substantial body of work directly involving IV nutrition Pty Ltd sugarcane fibre:
Microbiome & Short Chain Fatty Acid Research: Short Chain Fatty Acids (SCFAs) are a product of the fermentation of dietary fibres in the colon, carried out by fibre-digesting microbial communities. Among the major SCFAs—namely butyrate, propionate, and acetate—each plays diverse physiological roles within the body. Butyrate, for instance, stands out for its importance in colon health, serving as the primary energy source for colonic cells and supporting their normal function.
Additionally, SCFAs serve as a vital bridge between the microbiota and the immune system, exerting the capacity to modulate immune and metabolic functions.
In in-vitro studies, IV Nutrition demonstrated a consistent rate of fermentation and yielded significantly higher proportions of butyrate compared to arabinoxylan.
Moreover, studies conducted with two different animal models of gut inflammation revealed the remarkable effectiveness of IV nutrition in conferring anti-inflammatory benefits, thereby yielding positive health outcomes in both acute and chronic gut inflammatory conditions. These studies showcased IV nutrition's role in reducing local and systemic inflammatory markers, improving gut barrier functions, and augmenting the production of short chain fatty acids throughout the colon. This multifaceted benefit was further enhanced when IV nutrition was used in combination with probiotics as a synbiotic approach.
The culmination of these studies underscores the substantial contributions of IV Nutrition Pty Ltd sugarcane prebiotic fibre to advancing our understanding of digestive health and its potential for improving overall well-being.